Alamri Awadh, Alzahrani Dhaii, Alharbi Ghadi, Jan Rami, Alsubaie Lulu Abdullah, Alghamdi Amjad, Abualola Amal H, Jfri Abdulhadi
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Clin Cosmet Investig Dermatol. 2025 Jan 15;18:143-150. doi: 10.2147/CCID.S504281. eCollection 2025.
Acne vulgaris, a prevalent dermatological condition, often results in long-term complications such as scarring and hyperpigmentation. While extensive research has focused on treatment modalities, there is a notable gap in understanding the factors contributing to the development of acne scarring and post-inflammatory hyperpigmentation (PIH).
This study was conducted to identify the factors contributing to the development of acne scarring and post-inflammatory hyperpigmentation (PIH).
This retrospective cohort study, conducted at King Abdulaziz Medical City, Jeddah, Saudi Arabia, analyzed data from patients with acne vulgaris between 2016 and 2023 using the hospital's health information system, BESTCare. Statistical analysis was performed using RStudio (R version 4.3.1). We constructed a multivariable, multinomial logistic regression model to assess the independent predictors of four acne complication groups; no scarring/PIH, scarring alone, PIH alone, and acne scarring with PIH.
Among 417 analyzed participants, 95 participants had acne scarring (22.8%), 93 participants had PIH alone (22.3%), and 151 participants had both acne scarring with PIH (36.2%), and only 78 participants did not develop scarring or PIH (18.7%). Isotretinoin use and papules acne were associated with increased risk of acne complications. While adapalene gel was protective against acne scarring only.
This retrospective study sheds light on factors influencing acne scarring and PIH among Acne Vulgaris patients. Our findings provide valuable insights for tailoring interventions and advancing our understanding of acne vulgaris complications in the future.
寻常痤疮是一种常见的皮肤病,常导致疤痕和色素沉着等长期并发症。虽然广泛的研究集中在治疗方法上,但在理解导致痤疮疤痕和炎症后色素沉着(PIH)发展的因素方面存在明显差距。
本研究旨在确定导致痤疮疤痕和炎症后色素沉着(PIH)发展的因素。
这项回顾性队列研究在沙特阿拉伯吉达的阿卜杜勒阿齐兹国王医疗城进行,使用医院的健康信息系统BESTCare分析了2016年至2023年期间寻常痤疮患者的数据。使用RStudio(R版本4.3.1)进行统计分析。我们构建了一个多变量多项逻辑回归模型,以评估四个痤疮并发症组的独立预测因素;无疤痕/PIH、仅疤痕、仅PIH以及伴有PIH的痤疮疤痕。
在417名分析参与者中,95名参与者有痤疮疤痕(22.8%),93名参与者仅有PIH(22.3%),151名参与者既有痤疮疤痕又有PIH(36.2%),只有78名参与者未出现疤痕或PIH(18.7%)。使用异维甲酸和丘疹性痤疮与痤疮并发症风险增加相关。而阿达帕林凝胶仅对痤疮疤痕有保护作用。
这项回顾性研究揭示了影响寻常痤疮患者痤疮疤痕和PIH的因素。我们的研究结果为制定干预措施提供了有价值的见解,并有助于未来增进我们对寻常痤疮并发症的理解。